Dr. Bhide is an eminent scholar, Professor and Director of the Center for Brain Repair at Florida State University College of Medicine. He received his degree in veterinary medicine from Veterinary College, Bangalore, India, and PhD in Neuroscience from the University of Aberdeen, Scotland. He obtained Postdoctoral research training at the University College London, England, Yale University, New Haven, CT, Massachusetts General Hospital, Boston, MA and Harvard Medical School, Boston, MA. Dr. Bhide was an Associate Professor of neurology at Harvard Medical School and a Vice-Chair for neurology research at Massachusetts General Hospital, in Boston until 2011, when he accepted his current position at FSU. Dr. Bhide is a senior editor of the journal Developmental Neuroscience. He has served on various committees for a number of scientific organizations including the US National Institutes of Health, Veterans Administration, Autism Speaks and National Parkinson’s Foundation. Dr. Bhide founded Avekshan LLC, a Tallahassee based pharmaceutical company in 2014.
SELECTED PUBLICATIONS
- 1.McCarthy D.M., Morgan T.J., Lowe S.E., Wiliamson M.J., Spencer T.J., Biederman J., Biederman J., Bhide P. Nicotine exposure of male mice produces behavioral impairment in multiple generations of descendants. PLoS Biol. 2018;16:e2006497. doi: 10.1371/journal.pbio.2006497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Zhang L., Spencer T.J., Biederman J., Bhide P. Attention and working memory deficits in a perinatal nicotine exposure mouse model. PLoS One. 2018;13:e0198064. doi: 10.1371/journal.pone.0198064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Spencer T.J., Bhide P., Zhu J., Faraone S.V., Fitzgerald M., Yule A.M., Uchida M., Spencer A.E., Hall A.M., Koster A.J., Biederman J. Opiate antagonists do not interfere with the clinical benefits of stimulants in ADHD: A double-blind, placebo-controlled trial of the mixed opioid receptor antagonist naltrexone. J. Clin. Psychiatry. 2017;7 doi: 10.4088/JCP.16m11012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Jones L.C., Goode L., Davila E., Brown A., McCarthy D.M., Sharma N., Bhide P., Armata I. Translational effects and coding potential of an upstream open reading frame associated with DOPA responsive dystonia. Biochim. Biophys. Acta Mol. Basis Dis. 2017;1863:1171–1182. doi: 10.1016/j.bbadis.2017.03.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Biederman J., Fitzgerald M., Spencer T., Bhide P., McCarthy D., Wodworth K., Saunders A., Faraone S. Is paternal smoking at conception a risk for ADHD? A controlled study in youth with and without ADHD. J. Atten. Disord. 2017;5 doi: 10.1177/1087054717690809. [DOI] [PubMed] [Google Scholar]
- 6.Spencer T. J., Bhide P. G., Zhu J., Faraone S. V., Fitzgerald M., Yule A. M., Uchida M., Spencer A. E., Hall A. M., Koster A. J., Feinberg L., Kassabian S., Storch B., Biederman J. Does the mixed opioid receptor antagonist naltrexone mitigate stimulantinduced euphoria: A double-blind, placebo controlled trial of naltrexone. J. Clin. Psych. 2017;8 doi: 10.4088/JCP.17m11609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhu J., Fan F., McCarthy D., Zhang L., Cannon E., Spencer T., Biederman J., Bhide P. A prenatal nicotine exposure mouse model of methylphenidate responsive ADHD-associated cognitive phenotypes. Int. J. Dev. Neurosci. 2017;58:26–34. doi: 10.1016/j.ijdevneu.2017.01.014. https://www.ncbi.nlm.nih.gov/pubmed/28179105 [DOI] [PubMed] [Google Scholar]
- 8.Martin M., McCarthy D.M., Schatschneider C., Trupiano M.X., Jones S.K., Kalluri A., Bhide P.G. Effects of developmental nicotine exposure on frontal cortical GABA-to-non-GABA neuron ratio and novelty seeking behavior. 2019. (Cerebral Cortex). [Epub a head of print] [DOI] [PMC free article] [PubMed] [Google Scholar]